Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

The seroprevalence of Parvovirus B19 among kidney transplant recipients: a single-center study.

Khameneh ZR, Sepehrvand N, Sohrabi V, Ghasemzadeh N.

Saudi J Kidney Dis Transpl. 2014 Jan;25(1):16-21.

2.

Anemia as a complication of parvovirus b19 infection in renal transplant recipients.

Čapenko S, Kozireva S, Folkmane I, Bernarde K, Rozentāls R, Murovska M.

Medicina (Kaunas). 2012;48(6):299-304.

3.

Human parvovirus B19 in Iranian pregnant women: a serologic survey.

Khameneh ZR, Hanifian H, Barzegari R, Sepehrvand N.

Indian J Pathol Microbiol. 2014 Jul-Sep;57(3):442-4. doi: 10.4103/0377-4929.138748.

4.

Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.

van Elsacker-Neile AM, Kroon FP, van der Ende ME, Salimans MM, Spaan WJ, Kroes AC.

Clin Infect Dis. 1996 Dec;23(6):1255-60. Review.

PMID:
8953068
5.

Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study.

Park JB, Kim DJ, Woo SY, Choi GS, Chun JM, Jung GO, Kwon CH, Kim SJ, Joh JW, Lee SK.

Transpl Int. 2009 Apr;22(4):455-62. doi: 10.1111/j.1432-2277.2008.00818.x. Epub 2008 Dec 24.

6.

[Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].

Türk Dağı H, Ozdemir M, Baykan M, Baysal B.

Mikrobiyol Bul. 2010 Jul;44(3):467-72. Turkish.

PMID:
21063997
7.

Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia.

Plentz A, Würdinger M, Kudlich M, Modrow S.

J Clin Virol. 2013 Oct;58(2):443-8. doi: 10.1016/j.jcv.2013.07.007. Epub 2013 Jul 31.

PMID:
23916377
8.

Seroprevalence of parvovirus B19 in fibromyalgia syndrome.

Buyukkose M, Kozanoglu E, Basaran S, Bayramoglu O, Yarkin F.

Clin Rheumatol. 2009 Mar;28(3):305-9. doi: 10.1007/s10067-008-1044-4. Epub 2008 Dec 5.

PMID:
19057847
9.

Recurrent anemia in kidney transplant recipients with parvovirus B19 infection.

Renoult E, Bachelet C, Krier-Coudert MJ, Diarrassouba A, André JL, Kessler M.

Transplant Proc. 2006 Sep;38(7):2321-3.

PMID:
16980079
10.

Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.

Abiodun I, Opaleye OO, Ojurongbe O, Fagbami AH.

J Infect Dev Ctries. 2013 Dec 15;7(12):946-50. doi: 10.3855/jidc.3157.

11.
12.

Population-based study on the seroprevalence of parvovirus B19 in Amsterdam.

van Rijckevorsel GG, Sonder GJ, Schim van der Loeff MF, van den Hoek JA.

J Med Virol. 2009 Jul;81(7):1305-9. doi: 10.1002/jmv.21528.

PMID:
19475607
13.

Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.

Parsyan A, Addo-Yobo E, Owusu-Ofori S, Akpene H, Sarkodie F, Allain JP.

Transfusion. 2006 Sep;46(9):1593-600.

PMID:
16965589
14.

Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy.

Kuo SH, Lin LI, Chang CJ, Liu YR, Lin KS, Cheng AL.

J Clin Microbiol. 2002 Nov;40(11):3909-12.

15.

Renal anemia aggravated by long-term parvovirus B19 and cytomegalovirus infection in a renal transplant patient: case report and evaluation of B19 seroprevalence in dialysis patients.

Becker MR, Schneider B, Reber U, Pöge U, Klein B, Klehr HU, Zhou H, Fischer HP, Eis-Hübinger AM.

Transplant Proc. 2005 Dec;37(10):4306-8.

PMID:
16387104
16.

Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.

Liefeldt L, Plentz A, Klempa B, Kershaw O, Endres AS, Raab U, Neumayer HH, Meisel H, Modrow S.

J Med Virol. 2005 Jan;75(1):161-9.

PMID:
15543575
17.

Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study.

Varache S, Narbonne V, Jousse-Joulin S, Guennoc X, Dougados M, Daurès JP, Devauchelle-Pensec V, Saraux A.

Arthritis Care Res (Hoboken). 2011 Nov;63(11):1565-70. doi: 10.1002/acr.20576.

18.

Seroprevalence of human parvovirus B19 in a suburban population in São Paulo, Brazil.

Huatuco EM, Durigon EL, Lebrun FL, Passos SD, Gazeta RE, Azevedo Neto RS, Massad E.

Rev Saude Publica. 2008 Jun;42(3):443-9. Epub 2008 Apr 10.

19.

Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients.

Ki CS, Kim IS, Kim JW, Lee NY, Kim SH, Lee KW, Kim SJ, Joh JW, Huh WS, Oh HY.

Clin Transplant. 2005 Dec;19(6):751-5.

PMID:
16313320
20.

[Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].

Wei Q, Li Y, Wang JW, Wang H, Qu JG, Hung T.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2006 Jun;20(2):60-2. Chinese.

PMID:
16816866

Supplemental Content

Support Center